参考文献/References:
[1]张洋,王健,吴铮,等.层粘连蛋白对乙肝病毒感染相关肝癌患者术后复发的预测效果[J].中华医院感染学杂志,2020,30(20):3058-3061.[2]Jin S,Tan S,Peng W,et al.Radiofrequency ablation versus laparoscopic hepatectomy for treatment of hepatocellular carcinoma: a systematic review and meta-analysis[J].World J Surg Oncol,2020,18(1):199. [3]Liu Z,Zhou Y,Zhang P,et al.Meta-analysis of the therapeutic effect of hepatectomy versus radiofrequency ablation for the treatment of hepatocellular carcinoma[J].Surg Laparosc,Endosc Percutan Tech,2010,20(3):130-140. [4]Zytoon AA,Ishii H,Murakami K,et al.Recurrence-free survival after radiofrequency ablation of hepatocellular carcinoma. A registry report of the impact of risk factors on outcome[J].Jpn J Clin Oncol,2007,37(9):658-672. [5]Ganne-Carrié N,Nault JC,Ziol M,et al.Predicting recurrence following radiofrequency percutaneous ablation for hepatocellular carcinoma[J].Hepat Oncol,2014,1(4):395-408.[6]Liu Z,Wang S,Dong D,et al.The Applications of Radiomics in Precision Diagnosis and Treatment of Oncology: Opportunities and Challenges[J].Theranostics,2019,9(5):1303-1322. [7]Lambin P,Leijenaar RTH,Deist TM,et al.Radiomics: the bridge between medical imaging and personalized medicine[J].Nat Rev Clin Oncol,2017,14(12):749-762. [8]Yang Y,Xin Y,Ye F,et al.Early recurrence after radiofrequency ablation for hepatocellular carcinoma:a multicenter retrospective study on definition, patterns and risk factors[J].Int J Hyperthermia,2021,38(1):437-446. [9]陈敏山,陈敏华.肝癌射频消融治疗规范的专家共识[J].临床肝胆病杂志,2011,27(3):236-238,244.[10]Daimiel Naranjo I,Gibbs P,Reiner JS,et al.Radiomics and machine learning with multiparametric breast MRI for improved diagnostic accuracy in breast cancer diagnosis[J].Diagnostics,2021,11(6):919. [11]Montemezzi S,Benetti G,Bisighin MV,et al.3T DCE-MRI radiomics improves predictive models of complete response to neoadjuvant chemotherapy in breast cancer[J].Front Oncol,2021,11(4):630780.[12]Liang JD,Ping XO,Tseng YJ,et al.Recurrence predictive models for patients with hepatocellular carcinoma after radiofrequency ablation using support vector machines with feature selection methods[J].Comput Methods Programs Biomed,2014,117(3):425-434.[13]中华医学会肝病学分会.原发性肝癌二级预防共识(2021年版)[J].中华肝脏病杂志,2021,29(3):216-226.[14]Ning P,Gao F,Hai J,et al.Application of CT radiomics in prediction of early recurrence in hepatocellular carcinoma[J].Abdom Radiol (NY),2020,45(1):64-72. [15]Wen L,Weng S,Yan C,et al.A Radiomics Nomogram for Preoperative Prediction of Early Recurrence of Small Hepatocellular Carcinoma After Surgical Resection or Radiofrequency Ablation[J].Front Oncol,2021,11:657039.[16]Chong H,Gong Y,Pan X,et al.Peritumoral Dilation Radiomics of Gadoxetate Disodium-Enhanced MRI Excellently Predicts Early Recurrence of Hepatocellular Carcinoma Without Macrovascular Invasion After Hepatectomy[J].J Hepatocell Carcinoma,2021,8:545-563. [17]赵经纬,陈晓霞,郭晓东,等.CT影像组学模型预测肝移植术后肝癌早期复发的价值[J].武警医学,2021,32(5):399-402,406. [18]Guo D,Gu D,Wang H,et al.Radiomics analysis enables recurrence prediction for hepatocellular carcinoma after liver transplantation[J].Eur J Radiol,2019,117:33-40. [19]Hu C,Song Y,Zhang J,et al.Preoperative Gadoxetic Acid-Enhanced MRI Based Nomogram Improves Prediction of Early HCC Recurrence After Ablation Therapy[J].Front Oncol,2021,11:649-682. [20]Zhang L,Cai P,Hou J,et al.Radiomics Model Based on Gadoxetic Acid Disodium-Enhanced MR Imaging to Predict Hepatocellular Carcinoma Recurrence After Curative Ablation[J].Cancer Manag Res,2021,13:2785-2796.[21]Hui T,Chuah TK,Low HM,et al.Predicting early recurrence of hepatocellular carcinoma with texture analysis of preoperative MRI:a radiomics study[J].Clin Radiol,2018,73(12):1056.e11-1056.e16. [22]Yuan C,Wang Z,Gu D,et al.Prediction early recurrence of hepatocellular carcinoma eligible for curative ablation using a Radiomics nomogram[J].Cancer Imaging,2019,19(1):21. [23]郁义星,胡春洪,王希明,等.增强CT影像组学和机器学习在术前预测肝细胞癌微血管侵犯中的应用价值[J].中华医学杂志,2021,101(17):1239-1245.[24]Wang XH,Long LH,Cui Y,et al.MRI-based radiomics model for preoperative prediction of 5-year survival in patients with hepatocellular carcinoma[J].Br J Cancer,2020,122(7):978-985.
相似文献/References:
[1]王利娜,赵雪梅,徐云霞,等.磁共振扩散张量成像在肝细胞癌及
肝转移瘤鉴别诊断价值研究[J].医学信息,2018,31(09):12.[doi:10.3969/j.issn.1006-1959.2018.09.004]
WANG Li-na,ZHAO Xue-mei,XU Yun-xia,et al.Diagnostic Value of Magnetic Resonance Diffusion Tensor Imaging in Hepatocellular Carcinoma and Liver Metastases[J].Journal of Medical Information,2018,31(18):12.[doi:10.3969/j.issn.1006-1959.2018.09.004]
[2]孙 逊.性化护理对肝癌患者CT引导下射频消融术后
负性情绪及生活质量的影响[J].医学信息,2019,32(17):187.[doi:10.3969/j.issn.1006-1959.2019.17.065]
SUN Xun.Effect of Humanized Nursing on Negative Emotion and Quality of Life after
CT-guided Radiofrequency Ablation in Patients with Liver Cancer[J].Journal of Medical Information,2019,32(18):187.[doi:10.3969/j.issn.1006-1959.2019.17.065]
[3]刘 冰,杨 帅,费锡斌,等.GPC-3联合CK-19免疫组化检测在肝细胞癌诊断及鉴别诊断中的应用[J].医学信息,2019,32(23):169.[doi:10.3969/j.issn.1006-1959.2019.23.054]
LIU Bing,YANG Shuai,FEI Xi-bin,et al.Application of GPC-3 Combined with CK-19 Immunohistochemical Detection in Diagnosis and Differential Diagnosis of Hepatocellular Carcinoma[J].Journal of Medical Information,2019,32(18):169.[doi:10.3969/j.issn.1006-1959.2019.23.054]
[4]崔怀信,王 鹏,厉志洪,等.超声引导下射频消融术治疗乳腺良性结节的临床效果[J].医学信息,2020,33(13):103.[doi:10.3969/j.issn.1006-1959.2020.13.028]
CUI Huai-xin,WANG Peng,LI Zhi-hong,et al.Ultrasound-guided Radiofrequency Ablation for the Treatment of Benign Breast Nodules[J].Journal of Medical Information,2020,33(18):103.[doi:10.3969/j.issn.1006-1959.2020.13.028]
[5]彭莉蓉,黎村艳,史 杨.肿瘤微环境免疫细胞中差异lncRNA对肝细胞癌预后的预测价值[J].医学信息,2022,35(20):18.[doi:10.3969/j.issn.1006-1959.2022.20.005]
PENG Li-rong,LI Cun-yan,SHI Yang.The Predictive Value of Differential lncRNA in Tumor Microenvironment Immune Cells for the Prognosis of Hepatocellular Carcinoma[J].Journal of Medical Information,2022,35(18):18.[doi:10.3969/j.issn.1006-1959.2022.20.005]
[6]刘丽丽.CLCVP对肝细胞癌行腹腔镜肝叶切除手术相关指标及肝门阻断时间的影响[J].医学信息,2020,33(19):88.[doi:10.3969/j.issn.1006-1959.2020.19.025]
LIU Li-li.The Effect of CLCVP on the Operation-related Indexes and Port Occlusion Time in Patients with Hepatocellular Carcinoma Undergoing Laparoscopic Lobectomy[J].Journal of Medical Information,2020,33(18):88.[doi:10.3969/j.issn.1006-1959.2020.19.025]
[7]裴金仙,陈天狮,任巧晶,等.JAK2/STAT3通路在HBV相关肝细胞癌中表达及机制研究[J].医学信息,2022,35(24):59.[doi:10.3969/j.issn.1006-1959.2022.24.012]
PEI Jin-xian,CHEN Tian-shi,REN Qiao-jing,et al.The Expression and Mechanism of JAK2/STAT3 Pathway in HBV-related Hepatocellular Carcinoma[J].Journal of Medical Information,2022,35(18):59.[doi:10.3969/j.issn.1006-1959.2022.24.012]
[8]杨孟涛,汪 艇,杜 伟,等.miR-181b-5p靶向调控SPP1在肝细胞癌中过表达的临床意义及作用机制[J].医学信息,2022,35(24):79.[doi:10.3969/j.issn.1006-1959.2022.24.016]
YANG Meng-tao,WANG Ting,DU Wei,et al.Clinical Significance and Mechanism of miR-181b-5p Targeting to Regulate SPP1 Overexpression in Hepatocellular Carcinoma[J].Journal of Medical Information,2022,35(18):79.[doi:10.3969/j.issn.1006-1959.2022.24.016]
[9]孙莹莹,龚先琼.中药单体治疗肝细胞癌的研究[J].医学信息,2021,34(09):33.[doi:10.3969/j.issn.1006-1959.2021.09.008]
SUN Ying-ying,GONG Xian-qiong.Study on the Treatment of Hepatocellular Carcinoma with Chinese Medicine Monomer[J].Journal of Medical Information,2021,34(18):33.[doi:10.3969/j.issn.1006-1959.2021.09.008]
[10]唐 菀,张晓珣,柴 进.SLCO1B1在肝细胞癌中的表达及其对患者预后的影响[J].医学信息,2023,36(02):12.[doi:10.3969/j.issn.1006-1959.2023.02.002]
TANG Wan,ZHANG Xiao-xun,CHAI Jin.Expression of SLCO1B1 in Hepatocellular Carcinoma and its Effect on Prognosis[J].Journal of Medical Information,2023,36(18):12.[doi:10.3969/j.issn.1006-1959.2023.02.002]